Maze Therapeutics, Inc. - Common Stock, par value $0.001 (MAZE)

Historical Holders from Q1 2025 to Q3 2025

Symbol
MAZE on Nasdaq
CUSIP
578784100
Type / Class
Equity / Common Stock, par value $0.001
Shares outstanding
43.5M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
43M
Holdings value
$1.11B
% of all portfolios
0.009%
Grand Portfolio weight change
+0%
Number of holders
93
Number of buys
61
Number of sells
-17
Average Value change %
-0.01%
Average buys %
+0.001%
Average sells %
-0.006%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Maze Therapeutics, Inc. - Common Stock, par value $0.001 (MAZE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Third Rock Ventures IV, L.P. 13.9% $47.6M 6.07M Third Rock Ventures IV, L.P. Jan 31, 2025
ARCH Venture Fund X, L.P. 9.4% $32.3M 4.12M ARCH Venture Fund X, L.P. Mar 31, 2025
Deep Track Capital, LP 9.02% +30.1% $54.8M $12.8M 3.95M +30.6% Deep Track Capital, LP Jun 30, 2025
Frazier Life Sciences Public Fund, L.P. 7.7% -25% $46.5M -$15.2M 3.35M -24.7% Frazier Life Sciences Public Fund, L.P. Jun 30, 2025
JANUS HENDERSON GROUP PLC 7.3% +21.7% $83.1M $15.1M 3.21M +22.1% JANUS HENDERSON GROUP PLC Sep 30, 2025
GV 2019, L.P. 5.5% $18.9M 2.41M Alphabet Holdings LLC Mar 31, 2025
Matrix Capital Management Company, LP 3.5% -36.7% $42.9M -$21.6M 1.65M -33.5% Matrix Capital Management Company, LP Sep 30, 2025
Foresite Capital Fund IV, L.P. 1.4% -70% $15.8M -$47.9M 609K -75.2% James Tananbaum Sep 30, 2025

Institutional Holders of Maze Therapeutics, Inc. - Common Stock, par value $0.001 (MAZE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 43M $1.11B +$108M $25.93 93
2025 Q2 38.8M $477M -$14.3M $12.27 74
2025 Q1 40M $441M +$441M $11.01 68